Alto Neuroscience, Inc.
ANROFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Alto Neuroscience, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 3 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| 683 Capital Management, LLC | 2026-03-31 | 40,000 | $899K | SEC filing |
| WELLINGTON MANAGEMENT GROUP LLP | 2026-03-31 | 59,799 | $1.34M | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 3 | $67 | SEC filing |
| JENNISON ASSOCIATES LLC | 2026-03-31 | 386,426 | $8.69M | SEC filing |
| STIFEL FINANCIAL CORP | 2026-03-31 | 86,335 | $1.94M | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 666,188 | $15M | SEC filing |
| Diametric Capital, LP | 2026-03-31 | 10,315 | $232K | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 104,717 | $2.35M | SEC filing |
| Cornerstone Financial Management LLC | 2026-03-31 | 69 | $1.55K | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 46 | $919 | SEC filing |
| Catalyst Funds Management Pty Ltd | 2026-03-31 | 11,400 | $256K | SEC filing |
| AdvisorShares Investments LLC | 2026-03-31 | 41,023 | $922K | SEC filing |
| Vestal Point Capital, LP | 2026-03-31 | 2,064,075 | $46.4M | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 292,899 | $6.59M | SEC filing |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 2026-03-31 | 18,083 | $407K | SEC filing |
| Vivo Capital, LLC | 2026-03-31 | 1,035,551 | $23.3M | SEC filing |
| ROYAL BANK OF CANADA | 2026-03-31 | 41 | $1K | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 533 | $10.9K | SEC filing |
| Driehaus Capital Management LLC | 2026-03-31 | 486,726 | $10.9M | SEC filing |
| DIMENSIONAL FUND ADVISORS LP | 2026-03-31 | 39,324 | $884K | SEC filing |
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- ACADIAN ASSET MANAGEMENT LLC: 57,546 shares reported 2025-12-31; 60,076 shares reported 2026-03-31.
- TWO SIGMA INVESTMENTS, LP: 140,317 shares reported 2025-12-31; 216,099 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 118,156 shares reported 2025-12-31; 238,498 shares reported 2026-03-31.
- Farther Finance Advisors, LLC: 31 shares reported 2025-12-31; 11 shares reported 2026-03-31.
- ARMISTICE CAPITAL, LLC: 1,536,000 shares reported 2025-12-31; 912,000 shares reported 2026-03-31.
- Hudson Bay Capital Management LP: 34,789 shares reported 2025-12-31; 43,762 shares reported 2026-03-31.
- BANK OF AMERICA CORP /DE/: 11,092 shares reported 2025-12-31; 25,677 shares reported 2026-03-31.
- Optiver Holding B.V.: 20 shares reported 2025-12-31; 4 shares reported 2026-03-31.
- PERCEPTIVE ADVISORS LLC: 1,784,393 shares reported 2025-12-31; 2,009,893 shares reported 2026-03-31.
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC: 17,064 shares reported 2025-12-31; 17,018 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 287,435 shares reported 2025-12-31; 292,899 shares reported 2026-03-31.
98 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Alto Neuroscience, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2024-02-06 · Alpha Wave Global, LP: Larger than all 8 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2024-07-10 | Savitz Adam · CHIEF MEDICAL OFFICER | Common Stock | P — Open market or private purchase | +2,931 | 13.22 | SEC filing |
| 2024-07-09 | Savitz Adam · CHIEF MEDICAL OFFICER | Common Stock | P — Open market or private purchase | +10,681 | 12.53 | SEC filing |
| 2024-07-09 | Savitz Adam · CHIEF MEDICAL OFFICER | Common Stock | P — Open market or private purchase | +1,388 | 13.15 | SEC filing |
| 2024-03-28 | Smith Nicholas Conrad · CHIEF FINANCIAL OFFICER | Common Stock | P — Open market or private purchase | +4,550 | 16.56 | SEC filing |
| 2024-03-28 | Smith Nicholas Conrad · CHIEF FINANCIAL OFFICER | Common Stock | P — Open market or private purchase | +1,600 | 15.80 | SEC filing |
| 2024-02-06 | Smith Nicholas Conrad · CHIEF FINANCIAL OFFICER | Common Stock | P — Open market or private purchase | +1,563 | 16.00 | SEC filing |
| 2024-02-06 | Etkin Amit · PRESIDENT AND CEO | Common Stock | P — Open market or private purchase | +3,125 | 16.00 | SEC filing |
| 2024-02-06 | Savitz Adam · CHIEF MEDICAL OFFICER | Common Stock | P — Open market or private purchase | +17,000 | 16.00 | SEC filing |
Showing 8 of 9 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-27 | Miller Andrew Craig · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +26,000 | SEC filing |
| 2026-05-14 | Etkin Amit · PRESIDENT AND CEO | Common Stock | G — Bona fide gift | −400,000 | SEC filing |
| 2026-05-12 | Manji Husseini · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,958 | SEC filing |
| 2026-05-12 | Cox Christopher Nixon · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,958 | SEC filing |
| 2026-05-12 | Dreyfus Andrew · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,958 | SEC filing |
| 2026-05-12 | York Gwill · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,958 | SEC filing |
| 2026-05-12 | Sanchez Ramiro · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +10,958 | SEC filing |
| 2026-03-01 | Smith Nicholas Conrad · CHIEF FINANCIAL OFFICER & CBO | Common Stock | F — Payment of exercise price or tax by delivering securities | −2,806 | SEC filing |
Showing 8 of 23 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-07-03 | Hanley Jr. Michael Conick · CHIEF OPERATING OFFICER | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −125,000 | SEC filing |
| 2025-07-03 | Smith Nicholas Conrad · CHIEF FINANCIAL OFFICER & CBO | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −90,000 | SEC filing |
| 2025-07-03 | Hanley Jr. Michael Conick · CHIEF OPERATING OFFICER | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −8,000 | SEC filing |
| 2025-07-03 | Savitz Adam · CHIEF MEDICAL OFFICER | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −22,481 | SEC filing |
| 2025-07-03 | Savitz Adam · CHIEF MEDICAL OFFICER | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −33,008 | SEC filing |
| 2025-07-03 | Etkin Amit · PRESIDENT AND CEO | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −223,000 | SEC filing |
| 2025-07-03 | Savitz Adam · CHIEF MEDICAL OFFICER | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −76,000 | SEC filing |
| 2025-07-03 | Smith Nicholas Conrad · CHIEF FINANCIAL OFFICER & CBO | Employee Stock Option (Right to Buy) | D — Disposition to the issuer | −202,329 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.